Daxor CorpDXR
Price (close)
$11.01
Market cap
—
P/E
—
Revenue (FY)
$1.4M
Net income
-$7.2M
Dividend yield
—
1-year total return
-8.1%
Net margin
-496.8%
Revenue growth
-8.4%
Debt / equity
—
What Daxor Corp does.
manufacturing company which provides additional biotechnology services. Daxor Corporation was originally incorporated in New York
State as Iatric Corporation in May 1971 for cryobanking services and continues these services through its wholly-owned subsidiary,
Scientific Medical Systems. In October 1971, the name Iatric Corporation was changed to Idant Corporation. In May 1973, the name
Revenue and profit, by fiscal year.
| Fiscal year | 2009 | 2010 | 2011 |
|---|---|---|---|
| Revenue | — | $1.6M | $1.4M |
| Net income | — | $5.0M | -$7.2M |
| Free cash flow | — | -$6.0M | -$6.6M |
More on DXR.
- Daxor Corp summary
- Daxor Corp financial statements
- Daxor Corp key metrics
- Daxor Corp health scores and style box
- Daxor Corp earnings
- Daxor Corp dividends
- Daxor Corp valuation
- Daxor Corp ownership and insiders
- Daxor Corp peers
Figures from Daxor Corp's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.